Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min One of North Carolina's largest ...
Biogen, one of the world's largest biotechnology companies, plans to invest $2 billion and build a new manufacturing facility in Research Triangle Park. Why it matters: Biogen is one of RTP's largest ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Biogen is buying a Boston-area ...
Salanersen, which is designed for once-yearly dosing, is a potential successor to Biogen's blockbuster SMA drug Spinraza, which generated worldwide sales of nearly $1.55 billion last year and requires ...
One of the healthier stocks on the market Friday was veteran biotechBiogen (NASDAQ: BIIB). The company unveiled its final set of fundamentals for 2025, and it crushed analyst estimates for both ...
CAMBRIDGE, Mass. — Biogen on Tuesday held a ceremonial groundbreaking of its 16-story headquarters in Kendall Square, ushering in the latest phase of the neighborhood’s transformation from “Nowhere ...
Florida-based J. L. Bainbridge sold 119,376 shares of Biogen for an estimated $16.1 million in the third quarter. After the transaction, J. L. Bainbridge reported holding just 2,969 shares of Biogen ...
Idec Pharmaceuticals Corp. and Biogen Inc. announced yesterday that they would merge in a $6.8 billion deal that will create a powerhouse in the biotechnology industry, with the new company earning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results